MicroCore Bio(688321.SH) announced a profit forecast, expecting a consolidated net profit attributable to equity shareholders of approximately 30.06 million yuan in the first half of the year.

Zh tng cijng APP xn, wi xn shngw (688321.SH) pl 2025 nin bn nin d yj ygo, gngs yj 2025 nin bn nin d shxin yngy shur yu wi 4.07 y yun, tngb zngji 35%Yj 2025 nin bn nin d shxin gush y m gngs suyu zh de jngl r yu wi 3006.00 wn yun. Yj 2025 nin bn nin d shxin kuch fi jngchngxng sny hu gush m gngs suyu zh de jngl r yu wi 2119.00 wn yun. According to the news from the Zhitong Finance APP, Micron Biologicals (688321.SH) disclosed the performance forecast for the first half of 2025. The company is expected to achieve approximately 407 million yuan in operating income for the first half of 2025, an increase of 35% year-on-year. It is estimated that the net profit attributable to the owners of the parent company in the first half of 2025 will be approximately 30.06 million yuan. The estimated net profit attributable to the owners of the parent company after deducting non-recurring gains and losses in the first half of 2025 will be approximately 21.19 million yuan.